NEW YORK (GenomeWeb News) – Cancer diagnostics firm 20/20 GeneSystems and Yeda R&D, the technology transfer company of the Weizmann Institute of Science, today announced a collaboration aimed at commercializing a lung cancer test developed by researchers at Weizmann.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.